Workup and Management of Orthostatic Hypotension in a 74-Year-Old Female with CAD and Vascular Disease
The recommended workup for confirmed orthostatic hypotension in a 74-year-old female with CAD and vascular disease should include a thorough evaluation for reversible causes, medication review, and targeted testing, followed by a stepwise treatment approach starting with non-pharmacological measures before considering medications. 1
Initial Evaluation
Medication Review
- Identify and discontinue or modify medications that may cause or worsen orthostatic hypotension:
- Antihypertensives (especially vasodilators)
- Diuretics
- Antipsychotics
- Tricyclic antidepressants
- Alpha-blockers
- Cardiac glycosides (when used with midodrine) 2
Laboratory Testing
- Complete blood count (to rule out anemia)
- Basic metabolic panel (electrolytes, renal function)
- Liver function tests (especially if considering pharmacologic therapy) 2
- Blood glucose (to evaluate for diabetes)
- Thyroid function tests
Cardiovascular Assessment
- Coronary angiography is reasonable given patient's age >40 years and existing CAD and vascular disease 3
- Consider 64-detector-row or higher CTA if pretest probability of new CAD is low to intermediate 3
- Evaluate for cardiac causes of orthostatic hypotension (heart failure, arrhythmias)
Management Approach
Non-Pharmacological Interventions (First-Line)
- Increased salt intake (6-10g daily/1-2 teaspoons) unless contraindicated by heart failure or severe hypertension 1
- Compression garments (thigh-high compression stockings, abdominal binders) providing 30-40 mmHg of pressure 1
- Physical counter-pressure maneuvers (leg crossing, squatting, muscle tensing) 1
- Acute water ingestion (500ml, 30 minutes before anticipated orthostatic stress) 1
- Dietary modifications:
- Small, frequent meals (4-6 per day)
- Reduced carbohydrate content
- Increased dietary fiber and protein
- Avoiding alcoholic beverages 1
- Sleeping with head of bed elevated to prevent supine hypertension 2
Pharmacological Interventions (If Non-Pharmacological Measures Insufficient)
First-line medication: Midodrine (5-20mg three times daily, with last dose at least 3-4 hours before bedtime) 1, 2
Alternative first-line: Fludrocortisone (0.1-0.3mg daily) 1
- Monitor for fluid retention, hypokalemia, and supine hypertension
- Use cautiously in patient with CAD and vascular disease
Second-line options (if first-line inadequate):
Monitoring
- Regular blood pressure measurements in both supine and standing positions 1
- Monitor for supine hypertension (BP >180/110 mmHg) 1
- Evaluate treatment efficacy based on symptom improvement rather than absolute BP values 1
- Regular weight assessment to evaluate fluid status 1
- Electrolyte monitoring, particularly potassium and sodium 1
Special Considerations for This Patient
- Given patient's age and cardiovascular comorbidities, start medications at lower doses and titrate slowly 1
- Closely monitor for supine hypertension, especially with pharmacologic therapy 1, 2
- If using midodrine, be cautious with concomitant cardiac glycosides due to potential for bradycardia 2
- If beta-blockers are needed for CAD management, start at very low doses due to potential worsening of orthostatic hypotension 1
Common Pitfalls to Avoid
- Focusing on BP numbers rather than symptoms 1
- Overlooking non-pharmacological measures 1
- Improper timing of medications (administering vasopressors too close to bedtime) 1, 2
- Inadequate monitoring for supine hypertension 1, 2
- Failure to discontinue contributing medications 1
By following this comprehensive approach, orthostatic hypotension can be effectively managed in this elderly patient with significant cardiovascular comorbidities, improving quality of life while minimizing risks.